Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

News · June 12, 2024

ASCO 2024: Cancer Risk Differs With Type of Hormone Therapy in Postmenopausal Women

Estrogen-only therapy may increase risk for ovarian cancer, while estrogen-progestin therapy may lower risk for endometrial cancer

PracticeUpdate Editorial Team


Further Reading